Zicheng Lv

Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy

Luo Yingli, Xianyu Luo, Yi Ru et al. · Biomaterials Research · 2024 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes

Lei Xia, Zi-yun Qiao, Zijie Zhang et al. · EClinicalMedicine · 2022 · 37 citations · Full text

Medicine, Surgery, Clinical Epidemiology +12

Aggregation‐Induced Emission (AIE) and Magnetic Resonance Imaging Characteristics for Targeted and Image‐Guided siRNA Therapy of Hepatocellular Carcinoma

Yuchen Hou, Chao Zhang, Zijie Zhang et al. · Advanced Healthcare Materials · 2022 · 24 citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +17

Pembrolizumab in combination with LEnvatinib in participants with hepatocellular carcinoma before liver transplant as Neoadjuvant TherapY—PLENTY pilot study

Zicheng Lv, Xuelin Xiang, Junekong Yong et al. · International Journal of Surgery · 2024 · 24 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial

Dan Cui, Lei Xia, Donghua Shi et al. · Signal Transduction and Targeted Therapy · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17